Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

John T. Wei; Daniel Barocas; Sigrid Carlsson; Fergus Coakley; Scott Eggener; Ruth Etzioni; Samson W. Fine; Misop Han; Sennett K. Kim; Erin Kirkby; Badrinath R. Konety; Martin Miner; Kelvin Moses; Merel G. Nissenberg; Peter A. Pinto; Simpa S. Salami; Lesley Souter; Ian M. Thompson; Daniel W. Lin

doi:10.1097/JU.0000000000003491

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

John T. Wei, Daniel Barocas, Sigrid Carlsson, Fergus Coakley, Scott Eggener, Ruth Etzioni, Samson W. Fine, Misop Han, Sennett K. Kim, Erin Kirkby, Badrinath R. Konety, Martin Miner, Kelvin Moses, Merel G. Nissenberg, Peter A. Pinto, Simpa S. Salami, Lesley Souter, Ian M. Thompson, Daniel W. Lin

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Abstract

Purpose:The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer screening, biopsy, and follow-up. This is Part I of a two-part series that focuses on prostate cancer screening. Please refer to Part II for discussion of initial and repeat biopsies as well as biopsy technique.Materials and Methods:The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. The systematic review was based on searches in Ovid MEDLINE and Embase and Cochrane Database of Systematic Reviews (January 1, 2000-November 21, 2022). Searches were supplemented by reviewing reference lists of relevant articles.Results:The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsy, and biopsy technique.Conclusions:Prostate-specific antigen (PSA)-based prostate cancer screening in combination with shared decision-making (SDM) is recommended. Current data regarding risk from population-based cohorts provide a basis for longer screening intervals and tailored screening, and the use of available online risk calculators is encouraged.

Original language	English (US)
Pages (from-to)	46-53
Number of pages	8
Journal	Journal of Urology
Volume	210
Issue number	1
DOIs	https://doi.org/10.1097/JU.0000000000003491
State	Published - Jul 2023

Keywords

DRE
PSA
biopsy
early detection of prostate cancer
imaging
prostate cancer
prostate cancer screening
risk calculator
screening interval
shared decision-making

ASJC Scopus subject areas

Urology

Access to Document

10.1097/JU.0000000000003491

Cite this

Wei, J. T., Barocas, D., Carlsson, S., Coakley, F., Eggener, S., Etzioni, R., Fine, S. W., Han, M., Kim, S. K., Kirkby, E., Konety, B. R., Miner, M., Moses, K., Nissenberg, M. G., Pinto, P. A., Salami, S. S., Souter, L., Thompson, I. M., & Lin, D. W. (2023). Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. Journal of Urology, 210(1), 46-53. https://doi.org/10.1097/JU.0000000000003491

Wei, JT, Barocas, D, Carlsson, S, Coakley, F, Eggener, S, Etzioni, R, Fine, SW, Han, M, Kim, SK, Kirkby, E, Konety, BR, Miner, M, Moses, K, Nissenberg, MG, Pinto, PA, Salami, SS, Souter, L, Thompson, IM & Lin, DW 2023, 'Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening', Journal of Urology, vol. 210, no. 1, pp. 46-53. https://doi.org/10.1097/JU.0000000000003491

@article{1f128cdcd319449d9c4cd971a8fe2856,

title = "Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening",

abstract = "Purpose:The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer screening, biopsy, and follow-up. This is Part I of a two-part series that focuses on prostate cancer screening. Please refer to Part II for discussion of initial and repeat biopsies as well as biopsy technique.Materials and Methods:The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. The systematic review was based on searches in Ovid MEDLINE and Embase and Cochrane Database of Systematic Reviews (January 1, 2000-November 21, 2022). Searches were supplemented by reviewing reference lists of relevant articles.Results:The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsy, and biopsy technique.Conclusions:Prostate-specific antigen (PSA)-based prostate cancer screening in combination with shared decision-making (SDM) is recommended. Current data regarding risk from population-based cohorts provide a basis for longer screening intervals and tailored screening, and the use of available online risk calculators is encouraged.",

keywords = "DRE, PSA, biopsy, early detection of prostate cancer, imaging, prostate cancer, prostate cancer screening, risk calculator, screening interval, shared decision-making",

author = "Wei, {John T.} and Daniel Barocas and Sigrid Carlsson and Fergus Coakley and Scott Eggener and Ruth Etzioni and Fine, {Samson W.} and Misop Han and Kim, {Sennett K.} and Erin Kirkby and Konety, {Badrinath R.} and Martin Miner and Kelvin Moses and Nissenberg, {Merel G.} and Pinto, {Peter A.} and Salami, {Simpa S.} and Lesley Souter and Thompson, {Ian M.} and Lin, {Daniel W.}",

year = "2023",

month = jul,

doi = "10.1097/JU.0000000000003491",

language = "English (US)",

volume = "210",

pages = "46--53",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Early Detection of Prostate Cancer

T2 - AUA/SUO Guideline Part I: Prostate Cancer Screening

AU - Wei, John T.

AU - Barocas, Daniel

AU - Carlsson, Sigrid

AU - Coakley, Fergus

AU - Eggener, Scott

AU - Etzioni, Ruth

AU - Fine, Samson W.

AU - Han, Misop

AU - Kim, Sennett K.

AU - Kirkby, Erin

AU - Konety, Badrinath R.

AU - Miner, Martin

AU - Moses, Kelvin

AU - Nissenberg, Merel G.

AU - Pinto, Peter A.

AU - Salami, Simpa S.

AU - Souter, Lesley

AU - Thompson, Ian M.

AU - Lin, Daniel W.

PY - 2023/7

Y1 - 2023/7

N2 - Purpose:The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer screening, biopsy, and follow-up. This is Part I of a two-part series that focuses on prostate cancer screening. Please refer to Part II for discussion of initial and repeat biopsies as well as biopsy technique.Materials and Methods:The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. The systematic review was based on searches in Ovid MEDLINE and Embase and Cochrane Database of Systematic Reviews (January 1, 2000-November 21, 2022). Searches were supplemented by reviewing reference lists of relevant articles.Results:The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsy, and biopsy technique.Conclusions:Prostate-specific antigen (PSA)-based prostate cancer screening in combination with shared decision-making (SDM) is recommended. Current data regarding risk from population-based cohorts provide a basis for longer screening intervals and tailored screening, and the use of available online risk calculators is encouraged.

AB - Purpose:The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer screening, biopsy, and follow-up. This is Part I of a two-part series that focuses on prostate cancer screening. Please refer to Part II for discussion of initial and repeat biopsies as well as biopsy technique.Materials and Methods:The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. The systematic review was based on searches in Ovid MEDLINE and Embase and Cochrane Database of Systematic Reviews (January 1, 2000-November 21, 2022). Searches were supplemented by reviewing reference lists of relevant articles.Results:The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsy, and biopsy technique.Conclusions:Prostate-specific antigen (PSA)-based prostate cancer screening in combination with shared decision-making (SDM) is recommended. Current data regarding risk from population-based cohorts provide a basis for longer screening intervals and tailored screening, and the use of available online risk calculators is encouraged.

KW - DRE

KW - PSA

KW - biopsy

KW - early detection of prostate cancer

KW - imaging

KW - prostate cancer

KW - prostate cancer screening

KW - risk calculator

KW - screening interval

KW - shared decision-making

UR - http://www.scopus.com/inward/record.url?scp=85161328945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85161328945&partnerID=8YFLogxK

U2 - 10.1097/JU.0000000000003491

DO - 10.1097/JU.0000000000003491

M3 - Article

C2 - 37096582

AN - SCOPUS:85161328945

SN - 0022-5347

VL - 210

SP - 46

EP - 53

JO - Journal of Urology

JF - Journal of Urology

IS - 1

ER -

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this